Nucleix: Mathias Ehrich

Liquid biopsy company Nucleix has appointed Mathias Ehrich as its CSO. He was previously the cofounder, CSO, and chief medical officer of prenatal testing company Juno Diagnostics, which ceased commercial operations earlier this year. Ehrich also served as CSO and senior VP of research and development at Labcorp and in multiple leadership positions at Sequenom, which was acquired by Labcorp in 2016.